Wardwizard Healthcare Limited (formerly **Ayoki Mercantile Limited**) is an Indian listed entity undergoing a fundamental strategic transformation. Following a significant change in management control in **October 2023**, the company has pivoted from legacy trading and consultancy services toward a comprehensive healthcare and medicare ecosystem. Under the leadership of the **Wardwizard Group**, the company is positioning itself as a diversified player in clinical services, pharmaceuticals, and digital health. --- ### **Strategic Pivot and Corporate Evolution** The company’s trajectory was redefined by a **60%** stake acquisition via an open offer by a promoter group led by **Mr. Yatin Sanjay Gupte**. This transition included a relocation of the registered office to **Thane, Maharashtra**, and the establishment of a functional corporate hub in **Vadodara, Gujarat**. **Key Corporate Milestones:** * **Name Change:** Rebranded from Ayoki Mercantile Limited to **Wardwizard Healthcare Limited** to reflect its new core mission. * **Object Clause Overhaul:** Expanded the "Main Objects" of the company to include hospital management, pharmaceutical manufacturing, and medical education. * **Management Leadership:** Currently led by **Mr. Gaurav Jayant Gupte** (Chairman and Managing Director) and **Mr. Yuvraj Priyadarshi** (CEO). --- ### **Diversified Healthcare & Trading Ecosystem** The company has structured its operations to cover the entire healthcare value chain, supplemented by strategic trading activities. #### **1. Clinical & Hospital Services** * **Specialized Care:** Establishment of multi-specialty hospitals, **ICU** and **trauma units**, and maternity homes. * **Specialty Centers:** Focus on high-yield segments including **Oncology, Cardiology, Nephrology, and Orthopedics**. * **Diagnostics:** Operation of pathological labs, **X-ray/ECG** clinics, scan centers, and blood banks. #### **2. Pharmaceuticals & Wellness** * **Manufacturing:** Processing of **tablets, capsules, syrups, injections, and ointments** across Allopathic, Ayurvedic, and Homeopathic disciplines. * **Ayurvedic Focus:** Providing traditional treatments and the cultivation/harvesting of medicinal plants. * **Consumer Goods:** Production of nutraceuticals, vaccines, and personal care items (cosmetics, soaps, and hair care). #### **3. Digital Health & Ancillary Services** * **Tech-Enabled Care:** Development of **app-based** medical assistance, e-commerce health portals, and medical transcription services. * **Home Healthcare:** Delivery of medicines, physiotherapy, and home-collection diagnostic services. * **Education:** Management of medical colleges, nursing schools, and **CME (Continuing Medical Education)** programs. #### **4. Strategic Trading Operations** The company leverages its group heritage to trade in: * **Electric Vehicles (EVs):** Procurement and sale of EVs and spare parts. * **Consumer Goods:** Home appliances, frozen foods, beverages, and spices. --- ### **Capital Structure and Financial Capacity** To facilitate its aggressive expansion, the company has significantly increased its financial headroom and authorized capital. | Metric | Value / Limit | | :--- | :--- | | **Authorized Share Capital** | Increased from **₹7.50 Crore** to **₹57.50 Crore** (Sept 2024) | | **Paid-up Equity Capital** | **₹24.50 Lakhs** (**2,45,000** shares) | | **Long-Term Borrowing Limit** | **₹200 Crore** (Fund-based) / **₹200 Crore** (Non-fund) | | **Inter-Corporate Loan Limit** | Up to **₹100 Crore** to group entities | | **Preferential Issue** | **5,00,00,000 warrants** convertible at **₹10 per warrant** | **Historical Financial Performance (Audited):** The company is currently scaling from a low base, with **FY 2024-25** turnover reaching **₹41.70 Lakhs**, up from **₹13.50 Lakhs** in **FY 2022-23**. While historical cycles showed marginal net losses (e.g., **₹3.10 Lakhs** in FY23), the current focus is on capital expenditure and infrastructure building. --- ### **The Wardwizard Ecosystem: Related Party Framework** The company utilizes an extensive network of related party transactions (RPTs) to scale operations. For **FY 2026-27**, the following material transaction limits have been established: | Related Party Entity | Approved Limit | Nature of Transaction | | :--- | :--- | :--- | | **Wardwizard Medicare Pvt Ltd (WMPL)** | **₹50 Crore** | Medicines, healthcare services, and borrowings | | **Wardwizard Solutions India Pvt Ltd (WSIPL)** | **₹30 Crore** | EV trading, electronics, and business support | | **Wardwizard Innovations & Mobility Ltd (WIML)** | **₹30 Crore** | EV procurement and financial advances | | **Mangalam Industrial Finance Ltd (MIFL)** | **₹20 Crore** | Expansion funding and credit facilities | | **Wardwizard Foods and Beverages Ltd (WFBL)** | **₹20 Crore** | Frozen foods, beverages, and healthcare goods | | **Mr. Yatin Sanjay Gupte / Mr. Gaurav Gupte** | **₹15 Crore each** | Strategic advisory and financial transactions | | **Wardwizard Property Holding Pvt Ltd** | **₹11 Crore** | Property rent and healthcare business services | | **Aadvance Integrated Medicine Solution LLP** | **₹10 Crore** | Ayurvedic treatments and professional services | --- ### **Risk Factors and Operational Challenges** #### **1. Transitional and Execution Risks** * **Business Inactivity:** The company is in an exploratory stage; active healthcare operations have been temporarily suspended while management re-strategizes. * **Scalability:** Success depends on the ability to leverage the **"Wardwizard"** brand in a highly competitive and regulated medical market. #### **2. Regulatory and Compliance Lapses** * **SDD Non-compliance:** Failure to comply with **SEBI (Prohibition of Insider Trading) Regulations** for three consecutive quarters in **2025** due to lack of **PCS** certification. * **Secretarial Qualifications:** Recent failures to file **MGT-14** forms and a violation of **Reg. 29 of SEBI LODR** regarding prior intimation for a Board Meeting on **September 6, 2024**. * **Historical Liabilities:** Potential SEBI enforcement regarding a **2010-11** open offer failure by a former promoter. #### **3. Financial and Liquidity Profile** * **Going Concern:** Auditors issued an **"Emphasis of Matter"** regarding suspended operations, though the company maintains the ability to meet liabilities due within one year. * **Concentration Risk:** High reliance on related party borrowings and transactions, which currently exceed **10%** of annual consolidated turnover, classifying them as **Material RPTs**. --- ### **Investment Outlook** Wardwizard Healthcare Limited represents a **high-risk, high-reward turnaround play**. The company is transitioning from a shell-like entity into a capital-intensive healthcare provider. Investors should monitor the conversion of the **5,00,000 warrants**, the commencement of active hospital operations, and the company's ability to resolve its recent regulatory compliance track record.